Skip to content

Clinical trials

Phase 3 Lymphoma, B-Cell, Marginal Zone trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 3 Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20132
20212
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Active, not recruiting2
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
European Organisation for Research and Treatment of Cancer - EORTC2
German High-Grade Non-Hodgkin's Lymphoma Study Group2
BeOne Medicines1
Incyte Corporation1
International Extranodal Lymphoma Study Group (IELSG)1
MEI Pharma, Inc.1
Pentixapharm AG1
Regeneron Pharmaceuticals1
The Lymphoma Academic Research Organisation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone14
Lymphoma, Follicular11
Lymphoma, Non-Hodgkin6
Burkitt Lymphoma5
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, Large B-Cell, Diffuse5
Lymphoma, Large-Cell, Immunoblastic5
Lymphoma, Mantle-Cell5
Lymphoma4
Lymphoma, Large-Cell, Anaplastic3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.